Earnings Scheduled For March 28, 2022
Companies Reporting Before The Bell
• LGL Group (AMEX:LGL) is likely to report quarterly earnings at $0.10 per share on revenue of $7.20 million.
Earnings Outlook For CASI Pharmaceuticals
CASI Pharmaceuticals (NASDAQ:CASI) is set to give its latest quarterly earnings report on Monday, 2022-03-28. Here's what investors need to know before the announcement.
Analysts estimate that CASI Pharmaceuticals will report an earnings per share (EPS) of $-0.06.
CASI Pharma Reports Renewal Of Exclusive Distribution Deal For Evomela In China
CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, announced today, that the Company has entered into
12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers
Anixa Biosciences (NASDAQ:ANIX) stock moved upwards by 9.1% to $3.35 during Tuesday's after-market session. The company's market cap stands at $100.9 million.
The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx
Here's a roundup of top developments in the biotech space over the last 24 hours.
CASI Pharma, Bioinvent Report Approval Of Co.’s Clinical Trial Application For Study Of BI-1206 In Non-Hodgkins Lymphoma In China
~ NMPA approved BI-1206 CTA a novel anti-FcγRIIB
~~ Trials Expected to Enroll Patients starting in 1H 2022
ROCKVILLE, Md. and BEIJING, Dec. 10, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a U.S.
20 Stocks Moving in Monday’s Pre-Market Session
Gainers
Astra Space, Inc. (NASDAQ: ASTR) rose 39.6% to $13.30 in pre-market trading after declining around 3% on Friday. Astra Space recently reported a Q3 loss of $0.06 per share.
